What a Heart Attack Actually Feels Like in Women

If you are experiencing chest pain, shortness of breath, jaw or arm pain, or sudden severe fatigue right now, call emergency services. Do not read this article first.

The myth that women do not get chest pain during a heart attack is itself dangerous. Most do. The problem is not that women have silent or atypical heart attacks at high rates. The problem is what happens after a woman describes her symptoms to someone in a clinical setting.

The Mechanism

Myocardial infarction occurs when blood supply to a region of heart muscle is cut off long enough for cells to die. In the classic obstructive pattern, an atherosclerotic plaque ruptures or erodes, triggering thrombus formation that blocks a major coronary artery. The result is intense, sustained ischemia to the muscle that artery supplies. Pain receptors in the ischemic myocardium and pericardium transmit signals via the vagus nerve and cardiac sympathetic afferents, which is why cardiac pain radiates in patterns that have nothing to do with the chest wall itself: jaw, left arm, back between the shoulder blades, right arm, neck. These are referred pain patterns from shared spinal cord segments, not imagination.

Women under 55 who suffer MI are more likely than men of the same age to have the MI driven by mechanisms other than the classic plaque rupture. Spontaneous coronary artery dissection (SCAD), in which the inner arterial wall tears and creates a false lumen that compresses blood flow, accounts for a disproportionate share of MI in younger women, particularly during or shortly after pregnancy. Plaque erosion rather than rupture is another female-predominant mechanism. Coronary vasospasm, in which an artery transiently constricts to near-occlusion, produces ischemia and infarction without any fixed blockage visible afterward. Each of these mechanisms produces the same downstream result: oxygen-starved myocardium generating the same pain signals.

The nausea, vomiting, and profound fatigue that accompany MI in women more often than in men are not mysterious. Vagal activation during cardiac ischemia is the mechanism. The vagus nerve, which provides parasympathetic innervation to the gastrointestinal tract, is stimulated by the same cardiac afferent signals driving the pain. This produces nausea, sweating, and bradycardia alongside or instead of the chest pain itself. The symptom is physiologically generated, not a softer or less cardiac version of what men experience.

What the Evidence Shows

Chest pain or pressure is the most common symptom of acute myocardial infarction in women, as it is in men. 4 / Promising The VIRGO study (Lichtman et al., JAMA Internal Medicine, 2015), which enrolled 3,501 patients under age 55 who had experienced a confirmed MI, is the most granular dataset on this question. More than 85 percent of women in the VIRGO cohort reported chest pain or discomfort as part of their presentation. The belief that young women primarily present without chest pain is not supported by this data.

What the VIRGO data did document was a difference in accompanying symptoms and in what happened to women after they arrived for care. Young women with MI reported higher rates of nausea, fatigue, shortness of breath, and pain in locations other than the chest compared with young men with MI. These associated symptoms occur in men, but women reported them more often and were more likely to present with them as the dominant complaint. 4 / Promising

The VIRGO data also documented the care gap that follows from misattribution. Young women waited significantly longer than young men to call emergency services after symptom onset. They were less likely to believe they were having a heart attack even while the event was in progress. They were less likely to arrive by ambulance. At the hospital, young women with MI were less likely to be treated with aspirin at presentation and received guideline-recommended therapies at lower rates than men with the same diagnosis. These disparities were not explained by differences in MI severity alone.

A 2018 analysis from Bucholz and colleagues at Yale School of Medicine, published in Circulation, examined in-hospital mortality after MI across more than 800,000 hospitalizations and found that women under 55 had nearly twice the in-hospital mortality of men of the same age with the same diagnosis. Some of this excess reflects biological differences in MI type. A substantial component reflects the time lost to diagnostic delay.

The sex disparity in recognition begins before the hospital. A 2000 study by Dracup and colleagues documented that women with confirmed MI waited significantly longer before calling for help than men. The VIRGO team found this pattern persisted in the 21st century cohort: the median time from symptom onset to hospital arrival was longer for young women than young men. When the blocked artery is not opened, myocardial cells die at a rate of approximately 2 million cells per minute in an average-sized infarction. Self-delay is the largest modifiable factor in this time equation.

Attribution errors begin in the emergency department. A 2019 systematic review by Mehta and colleagues in the European Heart Journal found that women presenting with chest pain were more likely than men to have their symptoms attributed to non-cardiac causes, to receive psychological explanations, and to have cardiac testing delayed or incomplete. This pattern held across multiple health systems and did not fully explain itself by age or risk factor differences.

Non-ST-elevation MI, which requires troponin elevation over 3 to 6 hours to confirm, may have an entirely normal initial ECG. The initial ECG being normal does not rule out MI. It rules out ST-elevation MI, which is one of several MI types. Women are more likely than men to have NSTEMI relative to STEMI as their MI type. A woman with NSTEMI whose initial ECG is normal, who is told in the emergency department that her ECG is fine, has not received reassurance she can rely on. She has received an accurate but incomplete piece of information.

MINOCA, myocardial infarction with non-obstructive coronary arteries, is a diagnosis that disproportionately affects women and is systematically missed by clinical teams expecting a blocked artery. The AHA released a scientific statement on MINOCA in 2019 (Tamis-Holland and colleagues, Circulation) documenting that MINOCA accounts for 5 to 10 percent of all MI presentations and that women account for more than half of MINOCA cases. The underlying mechanisms include plaque erosion without rupture, coronary vasospasm producing transient occlusion, spontaneous coronary artery dissection, and microvascular spasm, none of which produce the fixed obstruction visible on angiography. A woman who has had an MI, receives a coronary angiogram showing no significant stenosis, and is told “your arteries are clear” has not received confirmation that no MI occurred. She has received confirmation that MINOCA is the likely mechanism, which requires a different diagnostic pathway and different management than obstructive MI. Without that reframing, she leaves the hospital with a missed opportunity to understand her disease.

High-Sensitivity Troponin: Why the Test Matters for Women Specifically

Troponin, the protein released into the bloodstream when cardiac muscle cells are injured, is the primary biochemical test for myocardial infarction. Understanding how the test works, how it is interpreted, and why sex differences in troponin levels affect diagnostic accuracy for women is clinically important when navigating an emergency department evaluation.

High-sensitivity troponin assays (hs-TnI and hs-TnT) are now the standard in most hospital systems, having replaced conventional troponin assays over the past decade. They detect myocardial injury at approximately 10-fold lower concentrations than conventional assays, which allows rapid rule-out protocols using measurements at 0 hours and 1 to 2 hours rather than the prior 6-hour window. In low-risk patients with an hs-troponin below the limit of detection at presentation and a delta that shows no rise, a negative MI result can be achieved within 1 to 2 hours. A value substantially above the upper reference limit at initial presentation rules in acute MI.

The sex-specific issue is biologically established. Women have lower baseline hs-troponin levels than men, reflecting smaller average cardiac muscle mass. The upper reference limit for hs-troponin is defined as the 99th percentile of a reference population. When that reference population is mixed-sex, the threshold is calibrated primarily by the male distribution, which is higher. A woman’s troponin value that is elevated relative to the female-specific 99th percentile may fall below the male-derived universal threshold, generating a false-negative result against the criterion the laboratory is applying.

Mueller and colleagues, publishing in Circulation in 2021, demonstrated in a prospective multicenter cohort of over 8,000 patients presenting with chest pain that using sex-specific hs-TnT thresholds improved detection of MI in women compared to a universal threshold, with higher sensitivity at equivalent specificity. The European Society of Cardiology guidelines have adopted sex-specific thresholds as preferred. American guideline adoption has been slower and inconsistent across hospital systems.

The practical implication: if a woman’s hs-troponin at presentation is reported as within normal limits, the interpretation depends on which threshold was applied. The clinically appropriate request is serial troponin measurements with awareness of the troponin trajectory over time. A rising troponin — even if both initial values fall within the hospital’s normal range — warrants clinical concern and continued evaluation. The diagnosis of MI requires integration of symptoms, ECG, and troponin trajectory together, not interpretation of any single value in isolation.

What to Do This Week

1. Know that chest pain is the primary symptom you are looking for, not its absence. The most common presentation of MI in women includes chest pressure, tightness, squeezing, or discomfort. Associated symptoms such as nausea, jaw pain, left arm pain, back pain, breathlessness, and unusual fatigue increase the concern further. If you are having these symptoms and they have lasted more than five minutes, call emergency services now rather than reading on.

2. Call emergency services rather than driving yourself. Ambulances provide pre-hospital ECG interpretation, can begin treatment before hospital arrival, and alert the catheterization lab that a patient is coming. The pre-hospital delay that costs the most myocardium is self-delay before calling. Women are statistically less likely to call an ambulance than men with the same symptoms. Change that calculation for yourself before you need to make it under pressure.

3. Do not accept a normal ECG as complete reassurance. If you are in an emergency department with chest pain, a normal initial ECG rules out ST-elevation MI. It does not rule out NSTEMI. Ask whether serial troponins will be drawn and when the results will be available. The standard protocol for ruling out MI requires troponin measurements over at least 3 hours, not a single normal ECG.

4. If prior symptoms were attributed to anxiety or gastrointestinal causes, name that history explicitly. Tell the treating clinician: “I have had chest pain before and was told it was anxiety. I am not confident that was correct.” This is not being difficult. This is providing clinical information that changes the probability the clinician should be assigning to cardiac causes before the workup is complete.

5. If you have had an MI and no one has discussed whether SCAD was evaluated, ask. SCAD is more common in younger women than atherosclerotic MI, is visible on angiography when the operator looks for it, and has different management implications than standard obstructive MI. Ask specifically: “Was spontaneous coronary artery dissection considered and evaluated?”

The correction to the public health message is not that women have different heart attacks than men. It is that women’s heart attacks are missed at higher rates than men’s, for reasons that are largely systemic and correctable. Knowing what you are looking for, calling for help without delay, and insisting on the right tests are the actions that close that gap at the individual level. The disease is not mysterious. The delay is what costs the muscle.

Women who have read this and recognize a prior episode they let pass without evaluation deserve a straightforward next step: a conversation with a cardiologist, a stress test, and if there is any doubt about what happened physiologically, a formal cardiac workup. An event that felt like it might have been a heart attack, occurred in the right symptom pattern, and resolved on its own should be taken seriously. The heart attack you survive without recognition is the one you are least protected against when it comes back.